This question concerns many patients considering or currently using this GLP-1 receptor agonist for weight management or type 2 diabetes
Going forward, the increased focus on preventive care, rise in obesity rates, growing awareness of cardiovascular and weight-loss benefits and expansion of insurance coverage for obesity treatments will drive the growth
Las alternativas incluyen cambiar a otro GLP-1, optimizar la dosis, terapia combinada con otros medicamentos, intervenciones intensivas de estilo de vida o ciruga baritrica en casos seleccionados
Research indicates that the drug slows down gastric emptying and may adversely affect digestive system functions
BOC Sciences provides a wide range of research chemicals and biochemicals including natural compounds, which is one of our key fields
THOMAS, CHARLES BENSON, ROSS BRAY, CHENG CAI TANG, CORINA LOGHIN